NCT00647712View on ClinicalTrials.gov

Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

Divalproex Sodium Extended-Release Tablets 500 mg

500mg, single dose fasting

DRUG

Depakote ER® Tablets 500 mg

500mg, single dose fasting

Trial Locations (1)

78759

Cedra Clinical Research, LLC., Austin

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY